Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download

  Breast Cancer

  Free Subscription

Articles published in Clin Exp Metastasis

Retrieve available abstracts of 28 articles:
HTML format

Single Articles

    November 2020
  1. FERIOLI M, Perrone AM, Buwenge M, Arcelli A, et al
    Electrochemotherapy of skin metastases from breast cancer: a systematic review.
    Clin Exp Metastasis. 2020 Nov 12. pii: 10.1007/s10585-020-10063.
    PubMed     Abstract available

    October 2020
  2. PARK SB, Hwang KT, Chung CK, Roy D, et al
    Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer.
    Clin Exp Metastasis. 2020 Oct 20. pii: 10.1007/s10585-020-10060.
    PubMed     Abstract available

    June 2020
  3. KNIER NN, Hamilton AM, Foster PJ
    Comparing the fate of brain metastatic breast cancer cells in different immune compromised mice with cellular magnetic resonance imaging.
    Clin Exp Metastasis. 2020 Jun 12. pii: 10.1007/s10585-020-10044.
    PubMed     Abstract available

    April 2020
  4. RAZMARA AM, Sollier E, Kisirkoi GN, Baker SW, et al
    Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer.
    Clin Exp Metastasis. 2020 Apr 25. pii: 10.1007/s10585-020-10033.
    PubMed     Abstract available

  5. ANSARI KI, Bhan A, Liu X, Chen MY, et al
    Astrocytic IGFBP2 and CHI3L1 in cerebrospinal fluid drive cortical metastasis of HER2+breast cancer.
    Clin Exp Metastasis. 2020 Apr 11. pii: 10.1007/s10585-020-10032.
    PubMed     Abstract available

  6. YOUNSI A, Riemann L, Scherer M, Unterberg A, et al
    Impact of decompressive laminectomy on the functional outcome of patients with metastatic spinal cord compression and neurological impairment.
    Clin Exp Metastasis. 2020;37:377-390.
    PubMed     Abstract available

  7. BROWN DA, Lu VM, Himes BT, Burns TC, et al
    Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis.
    Clin Exp Metastasis. 2020;37:341-352.
    PubMed     Abstract available

  8. CHENG JN, Frye JB, Whitman SA, Funk JL, et al
    Skeletal impact of 17beta-estradiol in T cell-deficient mice: age-dependent bone effects and osteosarcoma formation.
    Clin Exp Metastasis. 2020;37:269-281.
    PubMed     Abstract available

    February 2020
  9. HARTUNG F, Patil A, Meshram RJ, Weber GF, et al
    Gene expression signatures of site-specificity in cancer metastases.
    Clin Exp Metastasis. 2020;37:159-171.
    PubMed     Abstract available

    January 2020
  10. ALZUBI MA, Boyd DC, Harrell JC
    The utility of the "Glowing Head" mouse for breast cancer metastasis research.
    Clin Exp Metastasis. 2020 Jan 14. pii: 10.1007/s10585-020-10020.
    PubMed     Abstract available

    October 2019
  11. METCALF S, Dougherty S, Kruer T, Hasan N, et al
    Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer.
    Clin Exp Metastasis. 2019 Oct 19. pii: 10.1007/s10585-019-10000.
    PubMed     Abstract available

  12. FUJITA R, Hamano H, Kameda Y, Arai R, et al
    Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization.
    Clin Exp Metastasis. 2019 Oct 8. pii: 10.1007/s10585-019-09999.
    PubMed     Abstract available

    June 2019
  13. TACHTSIDIS A, Le AV, Blick T, Gunasinghe D, et al
    Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.
    Clin Exp Metastasis. 2019 Jun 12. pii: 10.1007/s10585-019-09977.
    PubMed     Abstract available

    May 2019
  14. ALZUBI MA, Sohal SS, Sriram M, Turner TH, et al
    Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts.
    Clin Exp Metastasis. 2019 May 8. pii: 10.1007/s10585-019-09968.
    PubMed     Abstract available

  15. LIU Y, Zheng H, Li Q, Li S, et al
    Discovery of CCL18 antagonist blocking breast cancer metastasis.
    Clin Exp Metastasis. 2019 May 6. pii: 10.1007/s10585-019-09965.
    PubMed     Abstract available

    October 2018
  16. QUAYLE LA, Ottewell PD, Holen I
    Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention.
    Clin Exp Metastasis. 2018 Oct 30. pii: 10.1007/s10585-018-9946.
    PubMed     Abstract available

  17. LIEDTKE C, Kolberg HC, Kerschke L, Gorlich D, et al
    Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST).
    Clin Exp Metastasis. 2018 Oct 15. pii: 10.1007/s10585-018-9938.
    PubMed     Abstract available

    September 2018
  18. KASOHA M, Bohle RM, Seibold A, Gerlinger C, et al
    Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases.
    Clin Exp Metastasis. 2018 Sep 20. pii: 10.1007/s10585-018-9937.
    PubMed     Abstract available

  19. KIRN V, Strake L, Thangarajah F, Richters L, et al
    ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases.
    Clin Exp Metastasis. 2018 Sep 1. pii: 10.1007/s10585-018-9935.
    PubMed     Abstract available

    August 2018
  20. PASTORIZA JM, Karagiannis GS, Lin J, Lanjewar S, et al
    Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer.
    Clin Exp Metastasis. 2018 Aug 22. pii: 10.1007/s10585-018-9932.
    PubMed     Abstract available

    June 2018
  21. YANG YX, Wei L, Zhang YJ, Hayano T, et al
    Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.
    Clin Exp Metastasis. 2018 Jun 8. pii: 10.1007/s10585-018-9901.
    PubMed     Abstract available

    May 2018
  22. NATHANSON SD, Krag D, Kuerer HM, Newman LA, et al
    Breast cancer metastasis through the lympho-vascular system.
    Clin Exp Metastasis. 2018 May 23. pii: 10.1007/s10585-018-9902.
    PubMed     Abstract available

    February 2018
  23. FINGLETON B, Lange K, Caldwell B, Bankaitis KV, et al
    Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example.
    Clin Exp Metastasis. 2018 Feb 26. pii: 10.1007/s10585-017-9872.
    PubMed     Abstract available

  24. KASOHA M, Unger C, Solomayer EF, Bohle RM, et al
    Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.
    Clin Exp Metastasis. 2018 Feb 10. pii: 10.1007/s10585-018-9878.
    PubMed     Abstract available

    January 2018
  25. GAREAU AJ, Brien C, Gebremeskel S, Liwski RS, et al
    Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
    Clin Exp Metastasis. 2018 Jan 11. pii: 10.1007/s10585-018-9874.
    PubMed     Abstract available

    December 2017
  26. PRESS DJ, Miller ME, Liederbach E, Yao K, et al
    De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
    Clin Exp Metastasis. 2017 Dec 29. pii: 10.1007/s10585-017-9871.
    PubMed     Abstract available

  27. SOON PS, Provan PJ, Kim E, Pathmanathan N, et al
    Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Clin Exp Metastasis. 2017 Dec 6. pii: 10.1007/s10585-017-9868.
    PubMed     Abstract available

    September 2017
  28. KHALIL AA, Ilina O, Gritsenko PG, Bult P, et al
    Collective invasion in ductal and lobular breast cancer associates with distant metastasis.
    Clin Exp Metastasis. 2017 Sep 11. doi: 10.1007/s10585-017-9858.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.